Cite
HARVARD Citation
Urun, Y. et al. (2019). Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study. Journal of oncology pharmacy practice. pp. 1658-1664. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Urun, Y. et al. (2019). Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study. Journal of oncology pharmacy practice. pp. 1658-1664. [Online].